scispace - formally typeset
V

Vassiliki Karantza

Researcher at Merck & Co.

Publications -  113
Citations -  21693

Vassiliki Karantza is an academic researcher from Merck & Co.. The author has contributed to research in topics: Pembrolizumab & Breast cancer. The author has an hindex of 38, co-authored 101 publications receiving 15600 citations. Previous affiliations of Vassiliki Karantza include Rutgers University & University of Medicine and Dentistry of New Jersey.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, +1287 more
- 01 Apr 2012 - 
TL;DR: These guidelines are presented for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.